Cancer Research UK - Men with a high genetic chance of bowel cancer could have lower risk with healthy lifestyles
Men with a high genetic risk of developing bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle, according to a Cancer Research UK-funded study published (link is external) in the journal Genetics in Medicine.
For example, men of 50 who have a high genetic risk of developing bowel cancer have a 29 per cent risk of developing the disease within the next 25 years. But by living healthily this risk could drop to as low as 13 per cent – if healthy lifestyles are equally beneficial across all the risk groups.
The study – by scientists at The Institute of Cancer Research, London (link is external) – combined genetic and lifestyle risk factors to help find men at the highest risk of developing bowel cancer.
It used mathematical models that included 37 different factors that could put people at risk of cancer to calculate how likely it was for a man to be diagnosed with bowel cancer over the next 25 years.
These factors included inherited genetic faults that increase the risk of bowel cancer, as well lifestyle factors affecting risk such as consumption of alcohol, red meat, and fruit and vegetables, body mass index (BMI), smoking habits, physical activity, aspirin use and inflammatory bowel disease.
The scientists estimate that 610 cases of bowel cancer could be prevented over the next 25 years in the UK if 10,000 men in the highest risk category had the healthiest lifestyle. For men in the lowest risk group, 70 cases of bowel cancer could be prevented.
Professor Richard Houlston, professor of molecular and population genetics at The Institute of Cancer Research, London, said: “Bowel cancer is one of the biggest cancer killers and the number of cases is going up in the Western world. We have made big strides in our understanding of the genetic and lifestyle factors that can contribute to the development of bowel cancer, and that gives us an opportunity to begin assessing people for their future risk. If we can identify people who are at strongly increased risk, through both genetic and lifestyle factors, we can begin to give them targeted health messages, aimed at helping them make choices that could prevent the disease.”
Jessica Kirby, Cancer Research UK’s senior health information manager, said: “We know that maintaining a healthy lifestyle reduces the risk of bowel cancer. More than half of bowel cancers could be prevented, largely through lifestyle changes such as being a non-smoker, keeping a healthy weight, drinking less alcohol, being physically active and eating a diet that is low in red and processed meat and high in fibre.”
For media enquiries please contact the Cancer Research UK press office on +44 203 469 8300 or, out-of-hours, the duty press officer on +44 7050 264 059.
Frampton and Houlston. Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors. Genetics in Medicine (2016). Doi: 10.1038/gim.2016.101.
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.